-
公开(公告)号：US20240156398A1
公开(公告)日：2024-05-16
申请号：US18512490
申请日：2023-11-17
发明人： Tae Hui KIM
IPC分类号： A61B5/00 , A61B5/0205 , A61B5/11 , G16H10/20
CPC分类号： A61B5/4815 , A61B5/0205 , A61B5/1115 , A61B5/4368 , A61B5/6891 , A61B5/7405 , A61B5/742 , G16H10/20
摘要： The present disclosure relates to a system and method for improving sleep quality, and particularly, to a system and method for improving sleep quality that can induce correct sleep behavior of a user by measuring objective sleep quality in a wearless state and measuring and analyzing subjective sleep quality in a user-friendly manner. The system for improving sleep quality according to an embodiment of the present disclosure includes: a mattress configured to measure objective sleep quality information of a user in a wearless type; a behavior correction assistance device disposed at a predetermined distance from the mattress; and an AI speaker configured to integrate and analyze objective sleep quality information measured by the mattress and subjective sleep quality information determined through Q&A with the user.
-
公开(公告)号：US20230270681A1
公开(公告)日：2023-08-31
申请号：US18114168
申请日：2023-02-24
发明人： Jaehong KEY , Sanghyo PARK
IPC分类号： A61K9/20 , A61K31/496 , A61K51/12 , A61K49/00 , A61P11/00 , A61P35/00 , A61K31/704 , A61P31/12
CPC分类号： A61K9/204 , A61K31/496 , A61K51/1244 , A61K49/0091 , A61P11/00 , A61P35/00 , A61K31/704 , A61P31/12
摘要： Provided is a lung disease drug delivery carrier. The lung disease drug delivery carrier includes a disc particle having a diameter of 2 μm to 4 μm. The disc particle is injected into the human body. The disc particle includes a polymer selected from the group consisting of polyglycolic acid (PGA), polylactide (PLA), polyglycolide (PG), polyphosphazene, polyiminocarbonate, polyphosphoester, polyanhydride, polyorthoester, and combinations thereof, polylactide-co-glycolide (PLGA), and a drug. The disc particle is decomposed after 24 hours after being injected into the human body and delivers or releases the drug into a lung. The lung disease drug delivery carrier is accumulated in the lung, and the lung disease includes pulmonary fibrosis.
-
公开(公告)号：US20230201444A1
公开(公告)日：2023-06-29
申请号：US17983692
申请日：2022-11-09
发明人： Hanyoung LEE , Yong Joon SEO , Ho Sung CHO
CPC分类号： A61M1/84 , A61F11/202 , A61M2210/0668
摘要： Provided is an otitis media treatment instrument and, more particularly, to an otitis media treatment instrument having a ventilation tube installed thereon, the otitis media treatment instrument including: a cutting sheath which is configured in a tube shape, and which has an inner diameter larger than the outer diameter of the ventilation tube; and a suction pipe formed to be able to move relative to the cutting sheath inside the cutting sheath along the longitudinal direction of the cutting sheath, the suction pipe having, on the front end portion thereof, an insertion portion having an outer diameter smaller than the inner diameter of the ventilation tube and having a fixing portion which extends toward the front end of the insertion portion, and which has an outer diameter larger than the inner diameter of the ventilation tube.
-
公开(公告)号：US11529261B2
公开(公告)日：2022-12-20
申请号：US16651036
申请日：2017-09-27
发明人： Hanyoung Lee , Yong Joon Seo , Ho Sung Cho
摘要： Provided is an otitis media treatment instrument and, more particularly, to an otitis media treatment instrument having a ventilation tube installed thereon, the otitis media treatment instrument including: a cutting sheath which is configured in a tube shape, and which has an inner diameter larger than the outer diameter of the ventilation tube; and a suction pipe formed to be able to move relative to the cutting sheath inside the cutting sheath along the longitudinal direction of the cutting sheath, the suction pipe having, on the front end portion thereof, an insertion portion having an outer diameter smaller than the inner diameter of the ventilation tube and having a fixing portion which extends toward the front end of the insertion portion, and which has an outer diameter larger than the inner diameter of the ventilation tube.
-
公开(公告)号：US20210106536A1
公开(公告)日：2021-04-15
申请号：US17108403
申请日：2020-12-01
发明人： Jaehong KEY , Sanghyo PARK
摘要： Provided is a lung disease drug delivery carrier, in which the carrier includes a disc particle made of polylactide-co-glycolide (PLGA), the disc particle contains therein a drug, the carrier delivers and/or releases the drug therein into a lung, and the disc particle has a size of 1 μm to 5 μm.
-
公开(公告)号：US20210000767A1
公开(公告)日：2021-01-07
申请号：US17029791
申请日：2020-09-23
发明人： Inho CHOI , Chan-Moon CHUNG
IPC分类号： A61K31/137 , A61P21/00
摘要： A muscular atrophy-inducing agent containing, as an active ingredient, a hypometabolism-inducing substance selected from the group consisting of 3-iodothyronamine (T1AM), [D-Ala2,D-Leu5] enkephalin (DADLE), 5′-adenosine monophosphate (5′-AMP), and hydrogen sulfide (H2S), and a method for preventing or treating muscular hypertrophy; and a method for shrinking facial muscle are proposed. The muscular atrophy study model can provide a study model for an economic muscular atrophy study by using a hypometabolism-inducing substance which can be mass-produced, has an effect which may be usefully used by verification for screening of a drug for preventing or treating muscular atrophy, and can be usefully used as a compositions for preventing or treating muscular hypertrophy and a composition for facial muscle shrinkage through the muscular atrophy effect.
-
公开(公告)号：US10072302B2
公开(公告)日：2018-09-11
申请号：US15101552
申请日：2013-12-05
发明人： Hye Young Lee , Hye Young Wang
IPC分类号： C12Q1/68 , C12Q1/70 , C12Q1/6886
CPC分类号： C12Q1/6886 , C12Q1/708 , C12Q2600/112 , C12Q2600/118 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16
摘要： There are provided an improved cervical cancer diagnosing method and a diagnostic kit for same. According to the present invention, it is possible to more rapidly and accurately provide a patient group requiring a clinical treatment and a prevention treatment in terms of a technical aspect to predict that the limitation of the existing HPV DNA test method can be overcome, automate the RNA extraction from eliminated cells, and more rapidly provide more objective and accurate results because the result analysis can be performed by software by using the real-time RT-PCR.
-
8.发明授权公开(公告)号：US09839880B2
公开(公告)日：2017-12-12
申请号：US14769849
申请日：2014-02-21
发明人： Soo Hong Noh , Jong Hun Lee , Danhong Kim , Jong chan Yi
CPC分类号： B01D63/02 , B01D63/024 , B01D63/04 , B01D65/02 , B01D65/08 , B01D2311/20 , B01D2313/04 , B01D2313/105 , B01D2313/13 , B01D2313/19 , B01D2313/21 , B01D2313/50 , B01D2317/02 , B01D2319/04 , B01D2321/2033 , B01D2321/2041 , B01D2321/2058 , C02F1/44
摘要： A water treatment device using a hollow fiber membrane module is provided, including: a water container filled with raw water; a hollow fiber membrane module installed in the water container and provided with hollow fiber membranes therein to perform water treatment by a water pressure difference; and a raw water supplying part positioned on the water container, and configured to supply the raw water into the water container through the hollow fiber membrane module, in which the hollow fiber membrane module causes the raw water supplied from the raw water supplying part collide with the hollow fiber membrane to move the hollow fiber membrane, so that it is possible to minimize contamination of the hollow fiber membrane, minimize use of energy using electricity, and wash the hollow fiber membrane by a physical method.
-
公开(公告)号：US11974970B2
公开(公告)日：2024-05-07
申请号：US17029791
申请日：2020-09-23
发明人： Inho Choi , Chan-Moon Chung
IPC分类号： A61P21/00 , A61K31/137 , A61K31/7076 , A61K33/04 , A61K38/08
CPC分类号： A61K31/137 , A61P21/00 , A61K31/7076 , A61K33/04 , A61K38/08
摘要： A muscular atrophy-inducing agent containing, as an active ingredient, a hypometabolism-inducing substance selected from the group consisting of 3-iodothyronamine (T1AM), [D-Ala2,D-Leu5] enkephalin (DADLE), 5′-adenosine monophosphate (5′-AMP), and hydrogen sulfide (H2S), and a method for preventing or treating muscular hypertrophy; and a method for shrinking facial muscle are proposed. The muscular atrophy study model can provide a study model for an economic muscular atrophy study by using a hypometabolism-inducing substance which can be mass-produced, has an effect which may be usefully used by verification for screening of a drug for preventing or treating muscular atrophy, and can be usefully used as a compositions for preventing or treating muscular hypertrophy and a composition for facial muscle shrinkage through the muscular atrophy effect.
-
公开(公告)号：US20220112515A1
公开(公告)日：2022-04-14
申请号：US17288253
申请日：2019-10-25
申请人： INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY , UNIVERSITY INDUSTRY FOUNDATION, YONSEI UNIVERSITY WONJU CAMPUS
发明人： Hong Jai Lee , Soo Ki Kim , Jae Seung Moon , Bo Young Shin , Jin Su Shin , Sang Kyou Lee
IPC分类号： C12N15/85 , C12N7/00 , A01K67/027
摘要： Disclosed herein are methods for producing virus-infected cell lines or animal models, wherein an enveloped virus including a lipid bilayer is mixed with a bile acid or a bile acid derivative, which allows the lipid bilayer to be replaced with a lipid bilayer derived from a target animal. Also disclosed herein are the virus-infected cell lines or animal models so produced and methods of screening a therapeutic candidate for a viral disease using the same.
-
-
-
-
-
-
-
-
-
搜索结果
36 条记录 (耗时 0.033 秒)
